Bohai Pharmaceutical (BOPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 9,344 | 21,889 | 18,025 | 14,097 | 8,088 |
| Depreciation Amortization | 1,664 | 5,524 | 4,855 | 3,224 | 1,606 |
| Income taxes - deferred | -29 | 64 | -149 | -42 | -4 |
| Accounts receivable | 3,967 | -2,785 | -7,704 | -6,694 | -2,044 |
| Accounts payable and accrued liabilities | 501 | 1,100 | 41 | -454 | 827 |
| Other Working Capital | -4,843 | -2,515 | -9,921 | -10,343 | -1,915 |
| Other Operating Activity | -4,119 | 1,729 | 7,673 | 7,157 | 1,227 |
| Operating Cash Flow | $6,486 | $25,006 | $12,819 | $6,945 | $7,785 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,463 | -460 | -195 | -182 | -27 |
| Net Acquisitions | N/A | -5,000 | -5,000 | -5,000 | -5,000 |
| Purchase Sale Intangibles | N/A | -6,472 | -6,518 | -6,512 | N/A |
| Other Investing Activity | -200 | -5,628 | -7,115 | -6,663 | -54 |
| Investing Cash Flow | $-2,664 | $-11,089 | $-12,310 | $-11,845 | $-5,081 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 14,610 | 14,653 | 14,666 | 14,653 | 4,866 |
| Other Financing Activity | -14,611 | -10,614 | -10,621 | -10,178 | -1 |
| Financing Cash Flow | $0 | $4,039 | $4,045 | $4,475 | $4,865 |
| Exchange Rate Effect | 8 | -1,596 | -236 | -137 | -75 |
| Beginning Cash Position | 23,309 | 6,948 | 6,948 | 6,948 | 6,948 |
| End Cash Position | 27,138 | 23,309 | 11,265 | 6,386 | 14,442 |
| Net Cash Flow | $3,829 | $16,361 | $4,317 | $-562 | $7,494 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,486 | 25,006 | 12,819 | 6,945 | 7,785 |
| Capital Expenditure | -2,463 | -460 | -195 | -182 | -27 |
| Free Cash Flow | 4,022 | 24,546 | 12,624 | 6,763 | 7,758 |